Neda Safarzadeh | IR |
Joseph Payne | President & CEO |
Andrew Sassine | CFO |
Padmanabh Chivukula | Chief Scientific Officer & Chief Operating Officer |
Seamus Fernandez | Guggenheim |
Yanan Zhu | Wells Fargo Securities |
Ashiq Mubarack | Citi |
Pete Stavropoulos | Cantor Fitzgerald |
Greetings, and welcome to the Arcturus Therapeutics Fourth Quarter 2022 Financial Update and Pipeline Progress Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing.